TY - JOUR
T1 - Pharmacy-based management for depression in adults
AU - Sampson, Stephanie J.
AU - Todd, Adam
AU - Walton, Nick
AU - Steele, Rachel
AU - Webster, Lisa
AU - Churchill, Rachel
AU - McMillan, Dean
AU - Gilbody, Simon
AU - Ekers, David
N1 - Funding Information:
• Tees, Esk and Wear Valleys NHS Foundation Trust (TEWV), UK. RS and RC time on this project is funded by TEWV as a matched contribution to a University of York ESRC Impact Accelaration Account award. • University of York, UK.
Funding Information:
• Economic and Social Research Council (ESRC), UK. SJS time on this project is part funded by the University of York ESRC Impact Accelaration Account (ES/M500574/1). • Northumberland, Tyne and Wear NHS Foundation Trust (NTW), UK. SJS time on this project is part funded by NTW as a matched contribution to a University of York ESRC Impact Accelaration Account award.
Funding Information:
David Ekers: Chief Investigator of the Community Pharmacy Mood Intervention Feasibility and Pilot Study funded by the National Institute for Health Research. This study is relevant to the subject matter of the review however, the author has no associated financial or commercial conflicts of interest.
Publisher Copyright:
© 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2019/4/2
Y1 - 2019/4/2
N2 - Some services provided by pharmacists may have positive effects on patient health, including improvedmanagement of blood pressure and physical function (de Barra 2018). Antidepressant management for depression is usually achieved through general practitioner (GP) contact andmonitoring,which typically involves regular appointments (e.g. every two to fourweekswithin the first three months) in order to assess response and tolerance to treatment (NICE 2018). Community pharmacists may be well placed to have a role in antidepressant management because of their unique pharmacotherapeutic knowledge and ease of access for patients. In the UK, there have been efforts to raise public awareness about the role that pharmacists can play as part of multidisciplinary team to better support people with managing their health conditions, including mental health problems (Royal Pharmaceutical Society 2018).
AB - Some services provided by pharmacists may have positive effects on patient health, including improvedmanagement of blood pressure and physical function (de Barra 2018). Antidepressant management for depression is usually achieved through general practitioner (GP) contact andmonitoring,which typically involves regular appointments (e.g. every two to fourweekswithin the first three months) in order to assess response and tolerance to treatment (NICE 2018). Community pharmacists may be well placed to have a role in antidepressant management because of their unique pharmacotherapeutic knowledge and ease of access for patients. In the UK, there have been efforts to raise public awareness about the role that pharmacists can play as part of multidisciplinary team to better support people with managing their health conditions, including mental health problems (Royal Pharmaceutical Society 2018).
UR - http://www.scopus.com/inward/record.url?scp=85063876678&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD013299
DO - 10.1002/14651858.CD013299
M3 - Article
AN - SCOPUS:85063876678
SN - 1469-493X
VL - 2019
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 4
M1 - CD013299
ER -